GAMBARAN PELAKSANAAN PMTCT DI RSUD DR. MOEWARDI SURAKARTA
HIV infection is a major health problem and an infectious disease that can affect maternal and child mortality. The hospital is the spearhead of the implementation of PMTCT, especially Prong III, which is the prevention of HIV transmission from HIV positive pregnant women to their babies. The purpose of this study was to explore the implementation of PMTCT in RSUD Dr. Moewardi Surakarta. The research was conducted using a qualitative research method with a case study design to collect in-depth information about how patients experience and behavior in participating in the PMTCT program. The main informants in this study were PLWHA who had / are currently receiving PMTCT services at RSUD Dr. Moewardi, totaling 6 people. Cross check informants were counselors, case managers, pediatricians, obstetricians, as well as VCT clinical administration staff at RSUD Dr. Moewardi who participated in the PMTCT program. The results showed that the implementation of PMTCT in RSUD Dr. Moewardi can run well according to the PMTCT guidelines from the Indonesian Ministry of Health. The experience of health workers in managing the PMTCT program and the integration of the program into several child polyclinics and Ponek made PMTCT services run well and received support from all health workers related to PMTCT services.
Pencegahan Penularan HIV dari Ibu ke Bayi. Jakarta: Kementrian Kesehatan Republik Indonesia; 2011. Available from: http://www.slideshare.net/koalisiaids/pedoman-pmtct-nasional. .
Kementerian Kesehatan . Pedoman Nasional Pencegahan Penularan HIV dari Ibu ke Anak (PPIA). Jakarta: Kementerian Kesehatan RI; 2012. Available from: http://spiritia.or.id/Dok/pedomanppia2012.pdf.
Kementerian Kesehatan. Pemodelan Matematika Epidemi HIV Di Indonesia Tahun 2008 - 2014. Jakarta: Kementerian Kesehatan RI; 2008. Available from: http://www.aids-ina.org/files/publikasi/pemodelan.PDF.
Lexy ML. Metodologi Penelitian Kualitatif. Bandung: Ramaja Rosdakarya; 2009.
Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS care. 2005 Jan;17(1):10-22. PubMed PMID: 15832830. Epub 2005/04/19. eng.
McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic. Clinical Infectious Diseases. 2001 September 1, 2001;33(5):700-5.
Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006 Nov;3(11):e438. PubMed PMID: 17121449. Pubmed Central PMCID: PMC1637123. Epub 2006/11/24. Eng
Option B/B+: Key Considerations for Country Programmes: IATT. Available from: http://emtct-iatt-v2.org.php54-1.dfw1-2.websitetestlink.com/wp-content/uploads/2013/03/Toolkit-Section-1.pdf.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of internal medicine. 2000 Jul 4;133(1):21-30. PubMed PMID: 10877736. Epub 2000/07/06. eng.
Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between Adherence to Antiretroviral Therapy and Human Immunodeficiency Virus Drug Resistance. Clinical Infectious Diseases. 2003 October 15, 2003;37(8):1112-8.
Tomaszewsk EP. Understanding HIV/AIDS Stigma and Discrimination. Human Rights Update. 2012.
UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. UNAIDS, 2012.
World Health Organization. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, Programmatic update. Geneva, Switzerland: World Health Organization; 2012.